Octave survey shows 74% of life sciences manufacturers face product recalls in past five years

• Octave Intelligence published its 2026 Pulse of Quality in Manufacturing survey on life sciences and pharma quality operations.
• Product recalls remained widespread, with 74% reporting at least one in five years; 46% put per-recall rectification at $10M-$49.9M.
• Labor or skills shortages hit 75% of respondents; 80% said shortages were hurting product quality.
• Compliance burdens rose, with 63% citing higher internal requirements; 70% reported more internal mandates or quality audits.
• AI use reached 38%; 47% planned deployment within two years; 63% expected higher spending on quality programs in 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Octave Intelligence plc published the original content used to generate this news brief on September 30, 2026, and is solely responsible for the information contained therein.